|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0035668,
umls-concept:C0035820,
umls-concept:C0039215,
umls-concept:C0087111,
umls-concept:C0205210,
umls-concept:C0243009,
umls-concept:C0441889,
umls-concept:C0542339,
umls-concept:C0679199,
umls-concept:C1274040,
umls-concept:C1512900,
umls-concept:C1522577,
umls-concept:C2603343
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-5-12
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The SMART study compared 2 strategies for using antiretroviral therapy-drug conservation (DC) and viral suppression (VS)-in 5,472 human immunodeficiency virus (HIV)-infected patients with CD4+ cell counts >350 cells/microL. Rates and predictors of opportunistic disease or death (OD/death) and the relative risk (RR) in DC versus VS groups according to the latest CD4+ cell count and HIV RNA level are reported.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-1899
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
197
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1145-55
|
|
pubmed:dateRevised |
2009-2-5
|
|
pubmed:meshHeading |
pubmed-meshheading:18476293-AIDS-Related Opportunistic Infections,
pubmed-meshheading:18476293-Anti-HIV Agents,
pubmed-meshheading:18476293-CD4 Lymphocyte Count,
pubmed-meshheading:18476293-Drug Administration Schedule,
pubmed-meshheading:18476293-HIV,
pubmed-meshheading:18476293-HIV Infections,
pubmed-meshheading:18476293-Humans,
pubmed-meshheading:18476293-Proportional Hazards Models,
pubmed-meshheading:18476293-RNA, Viral,
pubmed-meshheading:18476293-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
|
|
pubmed:affiliation |
Copenhagen HIV Programme (CHIP), Faculty of Health Sciences, University of Copenhagen, Panum Institute, 2200 Copenhagen N, Denmark. jdl@cphiv.dk
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Research Support, N.I.H., Extramural
|
